[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344714-105":59,"doc-detail-344714-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tumor-suppressor-gene-chondroadherin-opposes-migration-and-proliferation-in-breast-cancer-and-predicts-a-good-survival","Tumor suppressor gene chondroadherin opposes migration and proliferation in breast cancer and predicts a good survival","","Breast cancer management requires molecular prognostic markers and actionable therapeutic targets. This study evaluates chondroadherin (CHAD) as a prognostic biomarker and potential target by analyzing CHAD expression at mRNA and protein levels across multiple datasets, alongside survival and stage-related comparisons. Functional experiments using CHAD knockdown in T47D and ZR75-30 cells and CHAD overexpression in MDA-MB-231 assess effects on proliferation and migration. Enrichment analyses and Western blotting link CHAD-mediated inhibition of PI3K/Akt signaling to reduced metastasis propensity and improved outcomes, supporting a tumor suppressor role.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tumor-suppressor-gene-chondroadherin-opposes-migration-and-proliferation-in-breast-cancer-and-predicts-a-good-survival/344714/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tumor-suppressor-gene-chondroadherin-opposes-migration-and-proliferation-in-breast-cancer-and-predicts-a-good-survival/344714.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of the study on chondroadherin (CHAD) in breast cancer?","Question",{"text":112,"@type":113},"To determine how CHAD relates to breast cancer severity and patient survival and to evaluate CHAD as a therapeutic target.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do the experiments test CHAD’s effects on breast cancer cells?",{"text":117,"@type":113},"CHAD knockdown was performed in T47D and ZR75-30 cells to assess proliferation and migration, and CHAD overexpression was performed in MDA-MB-231 cells to evaluate reduced proliferation capability.",{"name":119,"@type":110,"acceptedAnswer":120},"What molecular pathway is associated with CHAD’s tumor-suppressing effects?",{"text":121,"@type":113},"Western blotting indicates that CHAD inhibits PI3K and Akt phosphorylation, and enrichment analyses highlight pathways including the PI3K/Akt pathway.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344714,1791105766,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Ma etal. Discover Oncology (2026) 17:228 [https://doi.org/10.1007/s12672-025-03196-6](https://doi.org/10.1007/s12672-025-03196-6)  \nDiscover Oncology  \nRESEARCH Open Access  \nTumor suppressor gene chondroadherin  opposes migration and proliferation in breast cancer and predicts a good survival  \nXiaoqing Ma1,2,3, Siyuan Yang1,2,3 and Lingxiang Liu 1,2,3*  \n*Correspondence: Lingxiang Liu [llxlau@163.com](llxlau@163.com)  \n1Department of Oncology, First Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu Province, P. R. China  \n2Department of Breast Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, P. R. China  \n3Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, P. R. China  \nAbstract  \nTo enhance breast cancer (BC) management, there is an urgent need for molecular prognostic markers and therapeutic targets. This study investigates the role of chondroadherin (CHAD) in BC prognosis and its potential as a therapeutic target, focusing on its correlation with cancer severity and patient survival. CHAD expression at both mRNA and protein levels was analyzed in multiple datasets, and survival analysis was conducted. Comparisons were made between groups with different metastasis tendencies, and associations with clinical and pathological stages were examined. CHAD knockdown in T47D and ZR75-30 cell lines was performed to assess effects on proliferation and migration. Overexpression of CHAD in the MDA-MB-231 cell line reduced cell proliferation capability. GO/KEGG enrichment analysis identified CHAD’s roles in molecular functions, cellular components, and biological processes. Western blotting evaluated CHAD’s impact on the PI3K/Akt signaling pathway. Results indicated that CHAD expression is significantly lower in high malignancy BC groups and is associated with poorer survival outcomes. Increased CHAD levels correlate with lower metastasis propensity and are typically seen in lower-grade BC patients. CHAD knockdown increased proliferation and migration in T47D and ZR75-30 cells. Enrichment analyses highlighted pathways like “focal adhesion,”“ECM receptor interaction,” “regulation of actin cytoskeleton,” and “PI3K/Akt pathway.” Western blotting confirmed that CHAD inhibits PI3K and Akt phosphorylation. In summary, CHAD serves as a tumor suppressor gene and potential prognostic biomarker in breast cancer by inhibiting cell migration and proliferation through cell adhesion and PI3K/Akt pathway inhibition. Reduced CHAD expression correlates with worse prognosis, suggesting its potential as a therapeutic target.  \nKeywords CHAD, Prognosis, Migration, Breast cancer, Proliferation, PI3K/Akt pathway  \n1 Introduction  \nBreast cancer (BC) is the most frequently diagnosed cancer among women worldwide and a leading cause of cancer-related mortality. Various factors contribute to the risk of developing breast cancer, such as female sex, age ≥50 years, and family history [1]. Breast cancer is divided into several subtypes, which guide treatment: Hormone  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use,","cbCaihCUFwP113K9","https://ap.wps.com/l/cbCaihCUFwP113K9","pdf",2751663,13,"English","# Abstract\n# Keywords\n# 1 Introduction","[{\"question\":\"What is the main purpose of the study on chondroadherin (CHAD) in breast cancer?\",\"answer\":\"To determine how CHAD relates to breast cancer severity and patient survival and to evaluate CHAD as a therapeutic target.\"},{\"question\":\"How do the experiments test CHAD’s effects on breast cancer cells?\",\"answer\":\"CHAD knockdown was performed in T47D and ZR75-30 cells to assess proliferation and migration, and CHAD overexpression was performed in MDA-MB-231 cells to evaluate reduced proliferation capability.\"},{\"question\":\"What molecular pathway is associated with CHAD’s tumor-suppressing effects?\",\"answer\":\"Western blotting indicates that CHAD inhibits PI3K and Akt phosphorylation, and enrichment analyses highlight pathways including the PI3K/Akt pathway.\"}]","Tumor suppressor gene chondroadherin opposes migration and proliferation in breast cancer and predicts a good survival | PDF",1790055032,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e482b8bbc0e30a7303d5baafa302f41.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09134ed87e48265bde9d149f74768e50.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11dadd45c741ec0763a55352ba53f908.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7095f092758707b58846cd4a595ba14.webp",980,1306]